Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Syngenta To Acquire Pasteuria Bioscience

by Melody M. Bomgardner
September 24, 2012 | A version of this story appeared in Volume 90, Issue 39

Swiss crop protection firm Syngenta has agreed to buy U.S.-based Pasteuria Bioscience for $86 million plus deferred payments of up to $27 million. Pasteuria produces biological products, derived from soil bacteria of the genus Pasteuria, to control plant-parasitic nematodes. The company’s first product, a seed treatment to control the soybean cyst nematode, is set to launch in the U.S. in 2014. The deal follows Bayer CropScience’s recent acquisition of biological pesticide maker AgraQuest and Monsanto’s alliance with Alnylam to develop biopesticides based on RNAi technology.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.